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Coordinate Regulation of B Cell Differentiation
by the Transcription Factors EBF and E2A
1993, 1995). Although the gene was named early B cell
factor based on its cell type distribution, Ebf is also
expressed in brain, adipose tissue, and olfactory epithe-
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University of California, San Francisco lium, where it was independently identified (Olf-1) (Hag-
man et al., 1991, 1993; Wang and Reed, 1993). TargetedSan Francisco, California 94143
disruption of Ebf in mice results in animals with a severe
defect in early B cell development, before any significant
recombination of DH-JH segments has occurred in theSummary
immunoglobulin heavy chain locus (Lin and Grosschedl,
1995). Interestingly, Ebf heterozygous mice exhibit anThe transcription factors EBF and E2A are required at
approximately 2-fold decrease in the number of cellsa similar step in early B cell differentiation. EBF and
in the pro-B lymphocyte compartment, indicating thatE2A synergistically upregulate transcription of endog-
normal B cell development depends on the presence ofenous B cell±specific genes in a non-B cell line. Here,
two wild-type Ebf alleles.we examine a genetic collaboration between these
E2A, the founding member of the bHLH family of tran-factors in regulating B lymphopoiesis. We find that
scription factors, is expressed ubiquitously in two spliceEbf1/2E2a1/2 mice display a marked defect in pro-B
forms, E12 and E47, which differ in their bHLH domainscell differentiation at a stage later than observed in
(Murre et al., 1989). E2A binds a DNA sequence termedthe single homozygous mutant mice. Pro-B cells from
E box (59 CANNTG), which is found in the promoters ofEbf1/2E2a1/2 mice show reduced expression of lymphoid-
many different cell type-specific genes (Murre et al.,specific transcripts, including Pax5, Rag1, Rag2, and
1994). Tissue specificity is, in part, determined by E2Amb-1. We also show that EBF directly binds and acti-
dimerization partners, as described for the E47-MyoDvates the Pax5 promoter. Together, these data show
interaction in myogenic differentiation (Murre et al.,collaboration between EBF and E2A and provide in-
1989; Lassar et al., 1991). A unique form of E2A existssight into the hierarchy of transcription factors that
specifically in B cells consisting of an E47 homodimer,regulate B lymphocyte differentiation.
termed BCF-1, or B cell factor-1 (Murre et al., 1991; Shen
and Kadesch, 1995). Although E2A is widely expressed,Introduction
targeted disruption of E2a produces viable animals that
have a severe and specific defect in early B cell develop-The differentiation of B lymphocytes from hematopoietic
ment, prior to the onset of Ig gene rearrangement (Bainprogenitors is a complex and strictly regulated process.
et al., 1994; Zhuang et al., 1994). E2a heterozygous mu-Stages of early B cell differentiation have been charac-
tant mice also exhibit an approximately 2-fold decreaseterized by sequential rearrangement of the immunoglob-
in the pro-B cell compartment.ulin (Ig) genes and by the ordered appearance or disap-
The pronounced similarity of the B cell differentiationpearance of proteins at the cell surface (Rolink and
phenotype in Ebf2/2 and E2a2/2 mice led us to exploreMelchers, 1993). This program of differentiation involves
the possibility of cooperation between EBF and E2Athe selective expression of genes that are characteris-
in regulating a B cell±specific differentiation program.tic of the B cell lineage. The correct temporal expres-
Ectopic expression of EBF and E2A in an immature he-sion of these cell type-specific genes is determined by
matopoietic cell line, Ba/F3, resulted in the transcrip-the action of lineage-restricted transcriptional regula-
tional activation of the endogenous l5 and VpreB genestors. Experiments using targeted gene disruptions have
(Sigvardsson et al., 1997). The promoters of both the l5shown that the loss of some transcription factors,
and VpreB genes contain functional binding sites forsuch as PU.1, affects multiple hematopoietic lineages,
EBF and E2A (Kudo et al., 1987; Sigvardsson et al.,whereas the loss of other transcriptional regulators spe-
1997). Strong transcriptional synergy was also observedcifically affects early B cell development (Scott et al.,
in transient transfection assays, suggesting that EBF1994). These transcription factors include EBF (early B
and E2A cooperate to directly activate at least two Bcell factor), E2A, and BSAP (Pax5) (Bain et al., 1994;
cell±specific targets. Although these results suggestedUrbanek et al., 1994; Zhuang et al., 1994; Lin and
a collaborative role for these transcription factors in theGrosschedl, 1995; Singh, 1996; Reya and Grosschedl,
regulation of B cell±specific genes in a tissue culture1998).
model, the experimental approach did not define a roleEbf encodes a B cell±specific transcription factor that
for collaboration between EBF and E2A in normal B cellbinds DNA as a homodimer using a novel DNA-binding
differentiation. Furthermore, we were unable to identifydomain and a dimerization domain related to the helix-
target genes for which EBF and E2A are necessary,loop-helix (HLH) motif of the basic helix-loop-helix
but not sufficient for activation. The early arrest of B(bHLH) family of transcription factors (Hagman et al.,
lymphocyte differentiation in the Ebf or E2a homozygous
mutants also obscured the identification of additional
* To whom correspondence should be addressed (e-mail: rgross@
target genes in vivo.lmb.uni-muenchen.de).
To examine the collaboration of EBF and E2A in vivo,² Present address: Gene Center, Institute of Biochemistry, University
of Munich, Feodor-Lynen Strasse 25, 81377 Munich, Germany. we adopted a genetic approach analogous to synthetic
Immunity
22
Figure 1. FACS Analysis of E17.5 Fetal Liver
Pro-B Lymphocytes
(A) Ebf1/2E2a1/2 fetal livers contain fewer pro-
B cells. Anti-CD43-FITC and anti-B220-PE
antibodies were used to stain fetal liver cells
from E17.5 littermates. Anti-B220 is used as
a pan-B cell marker, while anti-CD43 stains
only pro-B cells within the B cell population.
Cells shown in the FACS plots have been
gated on lymphocytic cells by forward and
side scatter to exclude debris and large gran-
ular cells. Numbers next to each box repre-
sent the percentage of lymphocyte gated
cells shown.
(B) Graphical representation of the percent-
age of mutant fetal liver pro-B cells, as com-
pared to wild-type at E17.5 dpc. In each litter,
the number of B2201 CD431 cells in a wild-
type animal was set at 100%; if there were
two wild-type animals, an average of the two
was used as 100%.
lethality experiments in yeast. In this approach, hypo- in the numbers of pro-B cells compared to wild-type
littermates and a 4- to 5-fold reduction relative to singlemorphic alleles of two distinct genes are combined and
the offspring analyzed for a compound mutant pheno- heterozygous littermate controls (Figure 1B). These data
indicate that the transcription factors, EBF and E2A,type. A synthetic effect of the two mutations would sug-
gest that the gene products act in the same genetic cooperatively regulate early B cell development.
pathway. Here, we show that Ebf and E2a act in the
same genetic pathway by creating mice deficient in one EBF/E2A Double Heterozygotes Exhibit a Defect
in the Transition of Pro-B Cellsallele of each gene. Ebf/E2a double heterozygous mice
exhibit a marked defect in B cell differentiation. The from Fraction B to Fraction C
The extensive molecular and phenotypic characteriza-analysis of these mice identifies new genetic targets of
EBF and E2A and reveals a collaboration between these tion of B cell differentiation allowed us to further define
the defect of Ebf/E2a double heterozygous mice (Li etfactors in normal B lymphopoiesis.
al., 1993; Hardy and Hayakawa, 1995). Fetal liver cells
were stained with antibodies to B220, CD43, HSA (heatResults
stable antigen), and a fourth marker, either BP-1 or
CD19, and analyzed by flow cytometry (Figure 2). TheAnalysis of Ebf/E2a Double Heterozygous Mice
Reveals a Defect in Early B Cell Development combination of these markers define pro-B cell popula-
tions as follows: the earliest population, Fraction A, isBased on previous observations that pro-B cell differen-
tiation is dependent on the gene dosage of Ebf or E2a, B2201CD431HSA2BP-12; Fraction B cells upregulate
HSA to become B2201CD431HSA1BP-12; last, Fractionwe predicted that we would be able to detect a synthetic
effect in mice heterozygous for mutations in both Ebf C cells upregulate BP-1 to become positive for all four
surface antigens.and E2a genes (Zhuang et al., 1994; Lin and Grosschedl,
1995). E2a1/2 and Ebf1/2 mice were crossed to generate As anticipated, Ebf and E2a single heterozygous mice
displayed an approximately 2-fold decrease specificallylitters that contained wild-type, Ebf, and E2a single or
double heterozygous pups. Ebf1/2E2a pups exhibited in the number of Fraction B pro-B cells (Figure 2A).
This result is consistent with previous observations inreduced postnatal viability. Therefore, we examined B
cell differentiation in fetal liver at E17.5 or E18.5, when homozygous single mutant mice that identified an abso-
lute requirement for EBF or E2A in the transition fromdouble heterozygotes were represented in expected
numbers. Fraction A to Fraction B (Bain et al., 1994; Zhuang et
al., 1994; Lin and Grosschedl, 1995). The double hetero-Fetal liver cells were labeled with antibodies against
the pan-B cell marker, B220, and CD43 (leukosialin), zygous embryos showed a 4-fold decrease in the num-
bers of Fraction B cells, indicating an additive effect ofwhich is expressed on pro-B cells, and subjected to
flow cytometry to determine the size of the pro-B cell the mutations in the Ebf and E2a genes. However, a
significantly more pronounced decrease in the numberscompartment (Figure 1A). This analysis revealed a
marked defect in the numbers of cells in the pro-B com- of pro-B cells was observed in Fraction C of the
Ebf1/2E2a1/2 mice in comparison to single heterozy-partment of the Ebf/E2a double heterozygous embryos
compared to wild-type embryos. Ebf or E2a single het- gotes (Figure 2A). From these data, we conclude that
EBF and E2A not only act independently to regulate theerozygous pups exhibited a 2- to 3-fold decrease in
pro-B cells relative to wild-type, consistent with pre- transition from Fraction A to B as previously shown but
act cooperatively to regulate further differentiation toviously published observations (Bain et al., 1994; Zhu-
ang et al., 1994; Lin and Grosschedl, 1995). Analysis of Fraction C. Thus, these experiments reveal two distinct
requirements for EBF and E2A in pro-B cell differenti-multiple litters showed that Ebf/E2a double heterozy-
gous fetal livers have, on average, a 9-fold reduction ation.
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Figure 2. Four-Color FACS Analysis of Fetal
Liver Pro-B Cell Differentiation
E18.5 fetal liver cells were stained with anti-
bodies against HSA-FITC, CD43-PE, BP-
1-biotin or CD19-biotin, and B220-APC to dis-
tinguish between pro-B cell fractions.
(A) Ebf1/2E2a1/2 fetal liver cells exhibit a de-
fect in the Fraction B to C transition. B2201
CD431 gated cells are shown. HSA2BP-12
cells represent Fraction A pro-B lympho-
cytes, HSA1BP-12 cells represent Fraction B,
and HSA1BP-11 represent Fraction C. Num-
bers in each quadrant signify percentage of
lymphocyte gated cells.
(B) Ebf1/2E2a1/2 fetal liver Fraction B cells ex-
press less CD19 on their surface than wild-
type Fraction B cells. B2201 CD431 BP-12
gated cells are displayed in histograms. The
number above the marker indicates percent
of Fraction B cells that are CD191.
To further characterize changes within Fraction B that Expression Levels of EBF and E47 but Not E12
Transcripts Are Constant in Pro-B Cellsmight indicate a problem in differentiation, we also ana-
lyzed the expression of CD19, considered a definitive One possible explanation for the differential defect be-
tween the first (Fraction A to B) and second (Fraction Bmarker of the B cell lineage (Rolink et al., 1996). This
surface antigen is upregulated in Fraction B pro-B cells to C) pro-B cell transitions would be a requirement for
higher levels of EBF and E2A in Fraction B. To examineand is a target of the transcription factor, BSAP (Pax5)
(Kozmik et al., 1992; Nutt et al., 1998). Compared to the expression levels of these genes during B cell differ-
entiation, wild-type E17.5 fetal liver cells were labeledlittermate controls, Ebf/E2a double heterozygous mice
have fewer CD191 cells and a lower percentage of with antibodies against B220, CD43, HSA, and BP-1,
and sorted by flow cytometry into three different pro-BCD191 cells within Fraction B (Figure 2B). This decrease
in the number of CD19-expressing cells may be due to cell Fractions, A, B, and C. The cDNA was normalized
relative to the levels of actin transcripts and amplifieddecreased expression of the CD19 gene itself or alterna-
tively due to a defect in the differentiation of Fraction B in a linear range as shown for IL7R (Figure 4A). Levels
of Ebf and E47 transcripts remained constant in pro-Bcells. Whatever mechanism accounts for this defect,
these data corroborate our conclusion that EBF and E2A cell Fractions A, B, and C, while levels of E12 transcripts
increased from Fraction A to B (Figure 4B). If a require-are coordinately required for normal differentiation of
Fraction B to Fraction C. ment for higher levels of E12 caused the marked block
in the transition of Fraction B to C in the Ebf1/2E2a1/2
fetal liver, we might also expect to detect a similar blockAdult Ebf1/2E2a1/2 Animals Show a Defect
in Bone Marrow B Cell Development of differentiation in the E2a1/2 fetal liver as well, which
we did not observe (Figure 2A). Therefore, the additionalEbf/E2a double heterozygous mice that survived to
adulthood were used to determine whether or not the developmental defect in the Fraction B to C transition
in Ebf1/2E2a1/2 mice is unlikely to be due to differentialfetal liver B cell defect was recapitulated in adult B
lymphopoiesis. Analysis of bone marrow cells from expression levels of either EBF or E2A. This develop-
mental defect could, however, reflect a pronounced syn-4-month-old mice with antibodies against B220 and IgM
revealed that the B220loIgM2 population, which includes ergy in the function of EBF and E2A at this stage of
differentiation or, alternatively, a collaboration of bothpro-B and pre-B cells, was significantly decreased in
Ebf1/2E2a1/2 mice (Figure 3A). We note that bone mar- transcription factors with another transcription factor.
row samples from Ebf1/2 and E2a1/2 single heterozygous
mice contain more pro-B cells than the wild-type lit-
termate, which is consistent with a delay at a subse- Expression of Critical Genes in Fraction B Is
Decreased in Ebf/E2a Double Heterozygotesquent stage in which cells are actively proliferating. The
numbers of B220hiIgM1 recirculating B lymphocytes are To understand the molecular basis of the B cell defi-
ciency in Ebf/E2a double heterozygous mice, we exam-also reduced, although analysis of splenocytes clearly
shows the presence of B cells (Figures 3A and 3B). In ined the expression of multiple genes known or pre-
sumed to regulate B cell development. Toward this end,a separate experiment, analysis of the spleen revealed
that B2201 lymphocytes in Ebf1/2E2a1/2 mice express we performed RT-PCR analysis on B2201 cell popula-
tions that were sorted from the fetal liver of E15.5 em-both surface IgM and IgD (data not shown), suggesting
that a certain percentage of developing B cells can prog- bryos using magnetic beads (Figure 4D; Table 1). At this
stage of mouse embryogenesis, very few pro-B cellsress to maturity and exit into the periphery. These data
indicate that bone marrow B cell development is also have progressed to Fraction C, as defined by expression
of the surface markers, BP-1 and HSA (Figure 4C). Toaffected in Ebf/E2a double heterozygous mice in a man-
ner similar to that observed in the fetal liver. control for a similar composition and number of sorted
Immunity
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Figure 3. Adult Ebf1/2E2a1/2 Mice Display a
Defect in B Cell Development
(A) Bone marrow from Ebf1/2E2a1/2 adult ani-
mals exhibits a pro-B cell defect. Bone mar-
row cells from 4-month-old littermates were
stained with anti-B220-PE and anti-IgM-
FITC. Early B cells are B220loIgM2, immature
B cells are B220loIgM1, and mature recirculat-
ing cells B220hiIgM1. Numbers next to the
black boxes indicate percentage of lympho-
cyte gated cells represented within the box.
(B) Ebf1/2E2a1/2 adult mice have fewer B lym-
phocytes in the spleen. Spleens from 4-month-
old littermates were isolated and stained with
anti-B220-PE antibodies. Numbers displayed
above the markers represent percentage of
lymphocyte gated cells.
B cells, we normalized the cDNA samples using RT- We also examined expression of the Pax5 gene, which
has been shown to control the transition from FractionPCR to detect IL-7 receptor (IL7R) transcript levels, which
were similar in FACS-sorted Fraction B cells of all geno- B to C in adult bone marrow B cell development (Ur-
banek et al., 1994; Nutt et al., 1997). We found that intypes (data not shown). Moreover, IL7R gene expres-
sion was previously shown to be unaffected in the Ebf double heterozygous pro-B cells, Pax5 expression was
significantly decreased, suggesting that Pax5 is geneti-homozygous mutant (Lin and Grosschedl, 1995). Ali-
quots of RT-PCR reactions were withdrawn at multiple cally downstream of both Ebf and E2a. Other genes
expressed at a reduced level in Ebf1/2E2a1/2 pro-B cellscycles to ensure amplification in the linear range (data
not shown). include the recombination activating genes, Rag1 and
Rag2. These data suggest that Rag gene expression,Analysis of the previously identified targets for EBF
and E2A, l5 and VpreB, revealed a significant reduction found in both B and T lymphocytes, is coordinately regu-
lated by B cell±specific transcription factors, raising thein Ebf1/2E2a1/2 fetal liver samples but not in wild-type,
Ebf, or E2a single heterozygous controls (Figure 4D). possibility that these genes are regulated distinctly in
Figure 4. RT-PCR Analysis of Fetal Liver Pro-B
Cells
(A) Semiquantitative bulk RT-PCR of wild-
type E17.5 FACS sorted Fraction B pro-B
cells shows that titration of input cDNA re-
sults in linear amplification of IL7R message
after 30 cycles.
(B) RT-PCR analysis of transcript levels in
wild-type E17.5 pro-B lymphocyte Fractions
A, B, and C. Thirty cycle reactions are shown
for EBF, E12, and E47; twenty cycles shown
for actin.
(C) E15.5 fetal liver contains few Fraction C
cells. FACS analysis of a representative 1/1
fetal liver at E15.5, stained with anti-HSA-
FITC, anti-B220-PE, and anti-BP-1-biotin.
Only B2201 cells are shown; numbers in each
quadrant indicate the percentage that each
fraction represents of all B2201 cells.
(D) Ebf1/2E2a1/2 fetal liver cells exhibit a sig-
nificantly altered profile of gene expression.
Bulk RT-PCR analysis of fetal liver cells mag-
netically sorted with beads coated with anti-
B220 antibody. Twenty-seven, thirty, and
thirty-three cycles of PCR were performed for
each set of primers to ensure amplification in
the linear range. For IL7R, l5, VpreB, Im, B29,
and mb-1, 30 cycles are shown; Rag2 and
Pax5 PCR reactions shown are the product
of 33 cycles.
(E) Ebf1/2E2a1/2 fetal livers have fewer VpreB-
expressing cells. Fetal liver cells from E17.5
animals were stained with anti-B220-PE and anti-BP-1-biotin. B2201BP-12 cells were sorted into 96-well plates and subjected to RT-PCR
analysis with primers to the VpreB gene. Each well represents two cells.
Combinatorial Control of B Lymphopoiesis
25
Table 1. Summary of RT-PCR Analysis
RT-PCR Summary
IL7-R 1111 Bcl-2 1111
Im 1111 Bcl-xL 1111
Mu8 1111 PU.1 1111
l5 1 BSAP 1
VpreB 11 CD19 11
SCID 1111 E12 111
Rag1 1 LEF-1 11
Rag2 1 Sox-4 1111
mb-1 11 TCF-4 1111
B29 111 Fgr 1111
Cdc25A 1111 Flk 1111
Cdc25B 1111 Blk 1111
Cdc25L 1111 lkaros-VI 1111
1/1 Ebf1/2 E2a1/2 Cell #
VpreB 28/36 6/36 2
Rag2 21/36 3/36 5
The symbols by each gene name represent the approximate level
of expression seen in RT-PCR done on Ebf1/2E2a1/2 samples com-
pared to a wild-type littermate control (1111). RT-PCR reactions
that showed a difference in expression were repeated with the same
samples to control for consistency, as well as with cDNA made from
Figure 5. EBF and E47 Form a Ternary Complex on Sequences fromseparate litters collected on different days. The last two rows of the
the l5 Promotertable represent data from two- or five-cell RT-PCR analysis, an
example of which is shown in Figure 4. The fractions represent the An electrophoretic mobility shift assay using a 68 bp probe derived
number of reactions giving a positive PCR result for VpreB or Rag-2 from the l5 promoter, which contains one E box and one EBF site,
out of total wells tested for that gene. All wells counted were positive is shown. In vitro transcribed and translated EBF and E47 proteins
in an actin RT-PCR assay. were added, along with 100-fold molar excess of competitor DNA
where indicated. Competitor oligonucleotides contain either an EBF
site from the mb-1 promoter (EBF) or the mE5 E box from the Ig
heavy chain enhancer (E2A). Complexes of different mobility are
both the lymphoid lineages. The introduction of a re- identified at the side of the panel.
arranged immunoglobulin transgene, encoding a HEL-
specific heavy and light chain, was not able to rescue
the defect in Ebf1/2E2a1/2 pro-B cell development (data wild-type or Ebf1/2E2a1/2 fetal liver into each well of a
96-well plate and performed RT-PCR on these samplesnot shown) as was observed for Rag2/2 mice (Goodnow
et al., 1988; Mason et al., 1992; Chen et al., 1994; Spano- using primers for VpreB or Rag-2 (Figure 4E; Table 1).
In Ebf1/2E2a1/2 samples, we observed a 4- and 7-foldpoulou et al., 1994). Mb-1 and B29, the signaling compo-
nents of the surface immunoglobulin complex, were dif- decrease, respectively, in the number of wells yielding
a positive RT-PCR signal for VpreB or Rag-2, comparedferentially affected by the loss of one Ebf and one E2a
allele. Mb-1 was expressed at a reduced level in to wild-type. All wells shown were positive in an actin
RT-PCR assay (data not shown). This analysis confirmsEbf1/2E2a1/2 pro-B cells, whereas B29 transcription was
only modestly affected. B29 transcription has been ob- the differences seen in the bulk RT-PCR assay and fur-
ther suggests that a lower dose of both transcriptionserved in hematopoietic cell types other than B cells,
whereas mb-1 expression is confined to the B-cell lin- factors reduces the frequency of gene activation in a
cell population, rather than lowering the level of geneeage (Wang et al., 1998).
We also examined the expression of other candidate activation in all cells.
target genes known to be expressed in Fraction B cells
that are involved in regulating gene expression, cell cy- EBF and E47 Form a Ternary Complex on Sequences
from the l5 Enhancer/Promotercle progression, signaling, and cell survival (Table 1).
Among these, only the transcription factor genes, E12, The observation that EBF and E2A act coordinately in
B cell development led us to examine whether this func-Lef1, and Sox-4, and the CD19 gene were found to be
modestly downregulated in Ebf1/2E2a1/2 pro-B cells. tional collaboration in vivo can be accounted for by
cooperative DNA binding of these transcription factors.Lef1 and CD19 are downstream targets for BSAP and
may be only indirectly regulated by EBF and E2A (Nutt We had previously identified multiple EBF- and E2A-
binding sites in the l5 enhancer/promoter, which wereet al., 1998). Taken together, these data identify a num-
ber of new genetic targets for the coordinate function important for transactivation by EBF and E47 (Sigvards-
son et al., 1997). This finding suggested that cooperationof EBF and E2A in the development of the B cell lineage
(summarized in Table 1). between EBF and E2A could, at least in part, be medi-
ated directly at the promoter. To look for the formationThe observed reductions in the RT-PCR assay on bulk
sorted cell populations could reflect fewer pro-B cells of a ternary complex, we performed an electrophoretic
mobility shift assay with sequences from the l5 pro-expressing the target transcripts or a reduction in the
level of target gene transcription in all of the Ebf1/2E2a1/2 moter with in vitro translated EBF and E47 proteins (Fig-
ure 5). Both proteins were able to bind to the l5 se-pro-B cells. To distinguish between these two possibili-
ties, we sorted several B2201BP-12 cells from either quence individually. Addition of increasing amounts of
Immunity
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Figure 6. EBF Binds and Transactivates the
Pax5 Promoter
(A) An electrophoretic mobility shift assay us-
ing a 34 bp probe derived from the 1.8 kb
Pax5 promoter (GenBank #AF148961) is
shown. In vitro transcribed and translated
EBF was added, with a 100-fold molar excess
of unlabeled competitor DNA where indi-
cated. Unlabeled competitor oligonucleo-
tides added were either the same DNA as
used for the probe (Pax5-EBF1-specific) or
DNA containing the mE5 E box (nonspecific).
The supershifted EBF:DNA:Ab complex re-
sulting from the addition of anti-EBF antise-
rum is indicated at the side of the panel.
(B) Transient transfections of NIH3T3 cells
with EBF result in activation of the Pax5 1.8
kb promoter in a luciferase reporter construct.
Fold induction represents relative light units
(RLU) normalized by the expression of CMV-
bgalactosidase and compared to the reporter
vector alone. Each bar represents duplicate
transfections, and the experiment shown is
representative of three different experiments.
EBF added to E47 resulted in the formation of a slower reporter construct. NIH3T3 cells were transiently trans-
fected with the reporter construct together with plas-migrating complex. This complex could be competed
away by the addition of excess unlabeled oligonucleo- mids expressing EBF or E2A (Figure 6B). EBF was able
to transactivate the Pax5 promoter up to 18-fold. E2Atides containing either an EBF- or E2A- binding site,
suggesting that both EBF and E2A proteins were present did not transactivate the Pax5 promoter in this assay,
consistent with a lack of functional E2A binding sites inin the complex. We therefore conclude that EBF and
E47 are able to form a cocomplex using physiological the 1.8 kb fragment. Furthermore, E2A and EBF together
did not activate to a greater degree than EBF alone. Abinding sites, which may contribute to the cooperativity
observed in vivo. covalently linked homodimer of E47 acted indistinguish-
ably from E47 in this assay (data not shown). The de-
crease in activation seen in EBF/E2A combinations isEBF Binds and Activates the B Cell±Specific
most likely due to a nonspecific toxicity to the cells byPax5 Promoter
the E2A proteins. All samples were normalized to theOur observations of coordinate regulation of the l5 gene
expression of CMV-bgalactosidase; however, we couldencouraged us to study a potentially more relevant tar-
not completely titrate out the observed nonspecific tox-get of EBF and E2A, the Pax5 gene. The expression of
icity of the E2A proteins. Although we were unable toPax5, as well as the disruption of B cell development in
show direct regulation of the Pax5 promoter by E2A,Pax52/2 mice, are consistent with the Pax5 gene being
additional cis-regulatory elements may be required toregulated by EBF and/or E2A (Adams et al., 1992; Ur-
allow the normal function of this promoter in B cells.banek et al., 1994). Furthermore, expression of E12 in
a macrophage-like cell line results in the expression of
both Ebf and Pax5 transcripts (Kee and Murre, 1998). Discussion
However, this study did not determine whether the Pax5
gene is a direct target of either EBF or E2A. We therefore Our experiments show that the loss of one allele each
of Ebf and E2a markedly affects the differentiation ofcloned 1.8 kb of sequence upstream of the murine B
cell±specific start site in exon 1A of the Pax5 gene (Buss- pro-B cells, compared to single heterozygous mice. No-
tably, the defect in double heterozygous mice occurslinger et al., 1996). Analysis of the promoter identified
multiple E box sequences, but none tested were found later in differentiation than that observed in single homo-
zygous mutant mice. Moreover, transcription of multipleto bind to either in vitro translated E12 or E47. A putative
EBF site (Pax5-EBF1) was identified 1121 bp upstream lymphocyte-specific genes is significantly affected in
Ebf1/2E2a1/2 mice. We show that EBF and E2A can formof the transcription start site and was used as a probe
in an electrophoretic mobility shift assay (Figure 6A). In a ternary complex at a target promoter, suggesting a
possible contribution to functional cooperativity at thevitro translated EBF bound to the radioactively labeled
Pax5-EBF1 site and was supershifted by anti-EBF anti- level of DNA binding. Finally, we show that EBF can
directly bind and regulate the Pax5 promoter. Together,sera. The EBF:DNA complex could be competed away
by specific but not nonspecific unlabeled competitor these data suggest that coordinate regulation by distinct
transcription factors is important in establishing tempo-oligonucleotides. These data suggest that EBF may reg-
ulate Pax5 in vivo by binding directly to the promoter. ral patterns of gene activation during B cell differenti-
ation.In order to test the function of the promoter, the 1.8
kb Pax5 genomic fragment was cloned into a luciferase Cell type-specific gene expression can be achieved,
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in principle, by transcriptional regulators that are dedi- function of E2A. Finally, the l5 promoter sequence con-
tains multiple EBF binding sites and E boxes that maycated to a given cell type or by the overlapping expres-
sion of transcription factors found in multiple cell types. be important for the synergistic function of these tran-
scription factors. In the physiological process of B cellCombinatorial gene control of differentiation has been
well established for myogenesis in which two muscle- differentiation, functional cooperativity of EBF and E2A
in activating target genes may be a combination of anyspecific transcription factors, MEF2 and the bHLH
protein, MyoD, cooperate to regulate specific gene ex- of these mechanisms.
Finally, a possible mechanism for synergy might de-pression (Molkentin et al., 1995). However, in B cell dif-
ferentiation, no such collaboration between distinct pend on the amount, or dose, of activators present. It
had been previously observed that mice heterozygoustranscription factors has been described to account for
cell type-specific expression. The E2A gene products, for Ebf or E2a exhibit an approximately 2-fold decrease
in the number of cells in the pro-B cell compartment,E12 and E47, are expressed ubiquitously, although the
homodimeric form of E47, termed BCF-1, is found only and the B cells were therefore sensitive to the gene
dosage of Ebf or E2a (Zhuang et al., 1994; Lin andin B cells (Murre et al., 1991; Shen and Kadesch, 1995).
Recent data suggest that formation of the E47 homodi- Grosschedl, 1995). Several examples of dose depen-
dence have been described in mice in which a null muta-mers is regulated by the formation of intermolecular di-
sulfide bonds and by protein dephosphorylation spe- tion in one allele results in a mutant phenotype that is
intermediate between the wild-type and homozygouscifically in B cells (Benezra, 1994; Sloan et al., 1996).
Conversely, the expression pattern of EBF is restricted mutant phenotypes, such as mice deficient in the gene
encoding the transcriptional coactivator, p300 (Yao etto B cells and several other nonlymphoid cell types (Hag-
man et al., 1993; Wang and Reed, 1993; Garel et al., al., 1998). At a molecular level, several mechanisms
could account for the dose dependence of a gene en-1997). Ectopic expression of E47 alone in non-B cell
lines does not result in the activation of B cell±specific coding a transcription factor. The multiplicity of tran-
scription factor binding sites in promoters, such as thegenes, although E47 has been shown to weakly induce
the expression of lymphoid genes such as Rag1, Rag-2, l5 promoter, might impose dose dependence if occu-
pancy of all binding sites is required for a transcriptionaland TdT (Schlissel et al., 1991; Choi et al., 1996). Like-
wise, ectopic expression of EBF in non-B cells only response and the factor binds in a noncooperative man-
ner. Similarly, the heterozygosity of a gene encoding aweakly activates B cell±specific genes (Sigvardsson et
al., 1997). In combination, however, EBF and E47 syner- rate-limiting factor in the assembly of a multi-protein
complex would decrease formation of the functionalgize to activate high levels of expression of two pro-B
cell±specific genes, l5 and VpreB in non-B cell lines. complex (Henikoff, 1996). The appearance of a dose-
dependent phenotype in mutant mice could also be theAs would be predicted, the l5 and VpreB genes were
expressed in Ebf1/2E2a1/2 mice at very low levels, show- result of monoallelic expression of a critical transcription
factor. Random inactivation of a critical gene in hetero-ing the synergy between EBF and E2A in an in vivo
model. zygous mutant mice would confer a null phenotype on
50% of the cells. Recent data show that the Pax5 geneTranscriptional synergy may be achieved by multiple
mechanisms. First, DNA-binding proteins may bind co- is expressed in a monoallelic manner (Nutt et al., 1999).
This is not the case for the E2a locus, since matureoperatively at a target promoter. We have been able to
observe a cocomplex on l5 enhancer/promoter se- B cells from mice containing one E2abgalactosidase
knockin allele express both the wild-type E2A proteinquences, containing both EBF and E47. However, we
have been unable to show any direct physical interaction and the E2Abgal fusion protein in the same cell (Zhuang
et al., 1994). However, the possibility of monoallelic ex-between EBF and E2A in coimmunoprecipitation experi-
ments using either in vitro translated proteins or B cell pression remains for the Ebf locus.
The specific stage at which pro-B cells fromextracts (data not shown). It is possible that stable asso-
ciation of the two proteins may require an intermediary Ebf1/2E2a1/2 animals are deficient is consistent with a
critical defect in transcription of either the mb-1 or theprotein, as found in the association of the transcriptional
coactivator, ALY with LEF-1 and AML-1, which regulate Pax5 genes, both of which affect the transition from
Fraction B to Fraction C (Urbanek et al., 1994; Torres etthe TCRa enhancer (Bruhn et al., 1997).
Second, transcription factors can exhibit a functional al., 1996). This defect is earlier than the B cell develop-
mental arrest observed in Rag12/2 and Rag22/2 micesynergy without physical interaction with each other,
possibly by contacting components of the general tran- (Mombaerts et al., 1992; Shinkai et al., 1992). Although
Rag1 and Rag2 are also expressed in T lymphocytes,scription or chromatin remodeling machinery (Hernan-
dez-Munain and Krangel, 1995). Consistent with this our observation that expression of the Rag genes is
reduced in Ebf/E2a double heterozygous mice stronglyview, previous experiments using a cell line, stably trans-
fected with EBF or E47, showed that EBF alone but not suggests that these genes are distinctly regulated in B
and T cells by lineage-specific factors, such as EBF orE47 could activate the endogenous l5 locus to a low
level, although E47 has strong activating potential in BCF-1. BSAP, a B lineage restricted transcription factor
encoded by Pax5, is known to affect the expression oftransient transfection assays (Sigvardsson et al., 1997).
In combination, however, both factors induced expres- genes such as CD19, mb-1, Lef1, and N-myc, and bind-
ing sites for BSAP have been identified in the promoterssion of the endogenous l5 locus to levels approaching
those found in a pro-B cell line. These data suggest that of many other B cell±specific genes, including l5 and
VpreB (Kozmik et al., 1992; Tian et al., 1997; Nutt et al.,the observed functional synergy may in part be due to
the ability of EBF to bind its target in nuclear chromatin, 1998). The requirement for BSAP in B cell differentiation
in fetal liver is earlier than in adult bone marrow, sinceperhaps making the locus available to the activating
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no B2201 cells are observed in the fetal liver of Pax5 of the downstream genes for which both EBF and E2A
null mice (Nutt et al., 1997, 1998). However, recent data are necessary but have also defined a novel physiologi-
suggest that the activity of BSAP is concentration de- cal requirement for these two transcription factors in B
pendent, indicating that some functions of BSAP may cell development. Further studies will be required to
be more susceptible to changes in BSAP levels than pinpoint additional targets of EBF and E2A that promote
others (Wallin et al., 1998). In the functionally hypomor- progression through the early stages of B lymphocyte
phic Ebf/E2a double heterozygotes, enough BSAP may differentiation.
be expressed to allow commitment to the B cell lineage
but an insufficient amount to regulate the transition from Experimental Procedures
Fraction B to C. Furthermore, both EBF and BSAP are
Miceregulators of the mb-1 gene (Hagman et al., 1991; Fitz-
E2abgal1/2 mice on a 129/Sv background were bred to Ebf1/2 micesimmons et al., 1996). Low levels of functional Iga, en-
on a C57BL/6J background to generate litters for RNA and FACS
coded by mb-1, may be insufficient to transduce impor- analysis. Animals used for most experiments were bred in a nonbar-
tant developmental signals. It has been reported that rier facility. Mice were genotyped by PCR using the following condi-
BSAP also regulates B cell proliferation (Wakatsuki et tions: E2a PCR, 948C for 30 sec, 608C for 30 sec, and 728C for 1
min for 30 cycles; Ebf PCR, 948C for 30 sec, 558C for 30 sec, andal., 1994). Likewise, EBF orthologs may be involved in
728C for 30 sec for 30 cycles. The following primers were used forcell cycle control, since the expression of String, a
the genotyping PCR reactions: E2a PCR (1) 59CCGAGCTCCTTAAAGcdc25-like cell cycle regulator, in mitotic domain 2 coin-
GCCTCA, (2) 59TTGTGGACATTTTCTAGGCAG, and (3) 59GTTGTGCcides with the expression of collier, the Drosophila or-
CCAGTCATAGCCG (Y. Zhuang); Ebf PCR (1) 59GCCAACAGCGAAAA
tholog of EBF (Crozatier et al., 1996). However, we were GACC, (2) 59GGAGCCTCACCATTGCTGTAGAG, and (3) 59ATGGCGA
unable to observe any change in the expression of the TGCCTGCTTGCCGAATA. Ig heavy and light chain (MD4) transgenic
CDC25 gene family members expressed in B lympho- mice and primers were provided by J. Cyster. PCR primers for MD4
genotyping are as follows: IgHF1 59GCGACTCCATCACCAGCGAT;cytes (data not shown). Given the striking conservation
IgHF2 59CTGGAGCCCTAGCCAAGGAT; and IgHR1 59ACCACAGACbetween collier and Ebf, we would predict that some
CAGCAGGCAGA.target genes would be conserved. It is intriguing to spec-
ulate that one conserved function of Ebf family members
Flow Cytometry
may be to regulate specific Pax genes. Our observations Fetal liver or bone marrow cells were collected in cold FACS buffer
support a direct role for EBF in the activation of Pax5. (13 PBS 1 2% fetal calf serum) and homogenized with a syringe.
Although we have not found any evidence for regulation Cells were layered over Lympholyte M (Cedarlane) and centrifuged
to remove erythrocytes and cellular debris. Cells remaining at theof the Pax5 promoter fragment by E2A, it is likely that
interface were collected and washed with FACS buffer. For eachanother regulatory element, such as an enhancer, is also
antibody staining, 1 3 106 cells were placed in a well and incubatedrequired for the proper expression of the Pax5 gene that
with anti-CD32/16 (anti-Fc receptor; PharMingen) for 10 min on ice
requires the activity of E2A and/or EBF. It has been to block nonspecific antibody staining. The cells were then washed
reported that 12 kb of 59 flanking sequence can direct and incubated with primary antibodies for 15 min on ice. For four-
high level B cell expression, although no specific regula- color analyses, cells were washed after primary staining and then
incubated with streptavidin-Red613 (Gibco BRL) for 15 min on ice.tory regions have yet been characterized (Busslinger
The cells were washed one final time before resuspension in prepa-and Nutt, 1998). The finding that Pax5 expression is
ration for flow cytometric analysis. All analysis was done using Cell-coordinately regulated by EBF and E2A, as shown by
quest software (Becton-Dickinson). All of the antibodies used in flowour genetic experiments, suggests a hierarchy among
cytometry experiments were obtained from PharMingen.
transcription factors that are known to be involved in
many different development processes (Murre et al., RT-PCR
1994; Mansouri et al., 1996; Wehr and Gruss, 1996). Fetal liver cells were either magnetically sorted with beads coated
The process of B cell differentiation appears to require with anti-mouse B220 antibody (Dynal) or FACS sorted (FACStar;
Becton Dickinson). Each sample shown represents one fetal liver;EBF and E2A individually and coordinately at different
no samples were pooled. For the two-cell RT-PCR experiment, cellsstages of development. The transcriptional synergy of
were sorted into 96-well plates (MJ Research) containing RT lysisEBF and E2A in vivo may be important in establishing
buffer as previously described (Klug et al., 1998). RNA for bulk RT-a specific temporal expression pattern within the B cell PCR was purified with Trizol (Gibco BRL). The samples were treated
lineage. Temporal regulation of the Pax5 gene by EBF with RQ1 DNase (Promega) before inactivation by phenol/chloro-
and E2A may be of particular importance as recent stud- form extraction and ethanol precipitation. The fetal liver bulk RNA
ies have implicated Pax5 in commitment to the B cell samples were then reverse transcribed with MMLV-RT (Gibco BRL).
The cDNA reactions were brought up to a final volume of 100 andlineage (M. Busslinger, personal communication). Both
5 ml used in an RT-PCR reaction. All bulk RT-PCR reactions wereEBF and E2A are expressed at the earliest stages of B
standardized by levels of b-actin or by levels of IL-7 receptor. Stan-cell differentiation and appear to individually regulate
dard RT-PCR conditions were as follows: 948C for 30 sec, 558C for 30
target genes at that stage. One of these target proteins sec, and 728C for 30 sec, using 0.1 ml of Taq polymerase (Boehringer
may then facilitate the functional collaboration between Mannheim) per reaction for the number of cycles indicated in the
EBF and E2A, which in concert would regulate target figure legend. Aliquots were withdrawn at 27, 30, and 33 cycles
genes required at a later stage of differentiation. In par- to determine the minimum amplification necessary for detection.
Primers used for bulk RT-PCR reactions have been described pre-ticular, for the regulation of the transition of Fraction B
viously except for the following, which were designed using Gene-to C of pro-B cell development, the synergistic action
works software (Lin and Grosschedl, 1995; Wasserman et al., 1995):of EBF and E2A may also involve collaboration with
Cdc25A (GenBank accession number U27323) (1) 59CAGAATCGAC
Pax5. Such a mechanism that is dependent on the col- CGAATCAGG, (2) 59TGTCCAGAGGCTTACCATGC; Cdc25L (L16296)
laboration of multiple factors would increase the accu- (1) 59CCACTCTGTGACATGAACGC, (2) 59CAGAGGAACAACAGGCT
racy of temporal regulation of gene expression. Our in TCC; Cdc25B (D16237) (1) 59CAAGAATGCTGTGAACCTGC, (2) 59TG
GTTCATGGGTCGGTAGTC; Tcf4 (IMAGE clones 444295/764951) (1)vivo cooperativity studies have not only identified some
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